Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Estrostep Fe Is Barr's Next Patent Challenge; Ortho-Novum Trial By Oct.

Executive Summary

Barr's patent challenge against Pfizer's Estrostep Fe is the generic company's latest step in attempting to expand its oral contraceptives franchise.
Advertisement

Related Content

Allegra Growth Expected At 20% Annually; Generic Impact Possible In 2004
Allegra Growth Expected At 20% Annually; Generic Impact Possible In 2004
Barr Generic Ortho-Novum 7/7/7 To Launch Nine Months Prior To Patent Expiry
Barr Generic Ortho-Novum 7/7/7 To Launch Nine Months Prior To Patent Expiry
Tambocor Dispute, FTC Report May Keep Generic Drugs On Congress' Agenda
Medicare Rx Benefit "More Significant" Than Waxman/Hatch Reform - Barr
Bayer Comparing Vardenafil To Viagra In Attempt To Gain Edge In ED Market
Barr Generic Tambocor Launch Planned For Fall Following Win In Patent Case
Barr Generic Tambocor Launch Planned For Fall Following Win In Patent Case
Geneva Claims Fluoxetine 10 Mg Cap Exclusivity; Barr Restates Cipro Income
Advertisement
UsernamePublicRestriction

Register

PS038373

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel